Xu found through experiments that taking a certain dose of propofol can effectively inhibit the proliferation of cancer cells in patients with liver cancer, propofol can increase the activity and content of transforming growth factor TGF-β1 in patients, thereby inhibiting liver cancer through the Smad2 signaling pathway cell proliferation rate [8]. Here, TGFB1 is linked to liver cancer.